Home > Insider Trading > Filing (0001209191-19-009652)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Global Research And Cso	No	Yes	No	No

Transaction Summary

Sold:	32,956 shares	Avg. Price: $180.22	Total Value: $5,939,188.17
Number of Shares After Transactions:	37,177 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-02-11	10,083	$179.46	60,050	No	4	S	Direct
Common Stock	Disposition	2019-02-11	15,836	$180.33	44,214	No	4	S	Direct
Common Stock	Disposition	2019-02-11	6,937	$181.03	37,277	No	4	S	Direct
Common Stock	Disposition	2019-02-11	100	$181.82	37,177	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $179.46 (range $178.75 to $179.74).
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $180.33 (range $179.77 to $180.74).
Open market sales reported on this line occurred at a weighted average price of $181.03 (range $180.76 to $181.52).